← Back to Trial

Study of JANX007 in Subjects With Metastatic Castration-Resistant Prostate Cancer (ENGAGER-PSMA-01)

Trial Locations

• University of Alabama at Birmingham Hospital Birmingham, Alabama, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Mayo Clinic Phoenix, Arizona, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• USC Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• UCLA Department of Medicine Los Angeles, California, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Hoag Memorial Hospital Presbyterian Newport Beach, California, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• University of California Davis Comprehensive Cancer Center Sacramento, California, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• UCSF Helen Diller Family Comprehensive Cancer Center San Francisco, California, United States
  • · [email protected] (opens in new tab)
• Yale New Haven Hospital New Haven, Connecticut, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Mayo Clinic Jacksonville, Florida, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• University of Chicago Medical Center Chicago, Illinois, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• University of Maryland Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• University of Minnesota Medical Center Minneapolis, Minnesota, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Mayo Clinic Rochester, Minnesota, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Washington University School of Medicine St Louis, Missouri, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Northwell Health R.J. Zuckerberg Cancer Hospital Lake Success, New York, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• NYU Langone Health Long Island Mineola, New York, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• NYU Langone Health New York, New York, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Memorial Sloan Kettering Cancer Center New York, New York, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Weill Cornell Medicine New York, New York, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Montefiore Medical Center The Bronx, New York, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• University of Cincinnati Medical Center Cincinnati, Ohio, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• The Ohio State University Columbus, Ohio, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Penn State Milton S. Hershey Medical Center Hershey, Pennsylvania, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Thomas Jefferson University Honickman Center Philadelphia, Pennsylvania, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• UPMC Hillman Cancer Center Pittsburgh, Pennsylvania, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Rhode Island Hospital Providence, Rhode Island, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Medical University of South Carolina Charleston, South Carolina, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Sarah Cannon Research Nashville, Tennessee, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Mary Crowley Cancer Research Dallas, Texas, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• University of Texas Southwestern Medical Center Dallas, Texas, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Houston Methodist Hospital Houston, Texas, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• University of Wisconsin Carbone Cancer Center Madison, Wisconsin, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Froedtert Hospital and the Medical College of Wisconsin Milwaukee, Wisconsin, United States
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Chris O'Brien Lifehouse (COBLH) Camperdown, New South Wales, Australia
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Southern Oncology Clinical Research Unit (SoCRU) Bedford Park, South Australia, Australia
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)
• Linear Clinical Research Ltd. Nedlands, Western Australia, Australia
  • Contact: Janux Therapeutics · 858-206-8471 · [email protected] (opens in new tab)